Pivotal Study of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema (DIAMOND-2)

Description

The primary objective is to evaluate the efficacy and safety of OCS 01 as compared to Vehicle in subjects with Diabetic Macular Edema (DME).

Conditions

Diabetic Macular Edema

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective is to evaluate the efficacy and safety of OCS 01 as compared to Vehicle in subjects with Diabetic Macular Edema (DME).

A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects with Diabetic Macular Edema

Pivotal Study of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema (DIAMOND-2)

Condition
Diabetic Macular Edema
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Oculis Investigative Site - Stanford Byers Eye Institute, Palo Alto, California, United States, 94303

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 85 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Oculis,

    Diana Do, MD, PRINCIPAL_INVESTIGATOR, Stanford Byers Eye Institute

    Study Record Dates

    2026-06